News About: Pharm. Industry
Doctors’ antipathy over leading drugmakers perplexes salespeople
The Korean Medical Association has recently decided to accept a revised law that punishes doctors for shady deals with drug makers.
Nevertheless, some physicians’ open attitude to prevent the visit of salespeople i...
Plavix sales in April are staggering
Sanofi-Aventis’s blood thinner Plavix posted 45.5 billion won in April this year, down 5.7 percent compared with 48.2 billion won during the same period of last year, according to Ubist.
Other drug makers producing...
Whanin buys 6.22% stake in Ildong Pharm
Whanin Pharmaceutical said on May 13 it holds 6.22 percent stake in Ildong Pharmaceutical, increasing suspicions over the latter’s real intention.
Whanin bought 260,000 shares on May 13 in addition to the existing ...
Illegal practice is still prevailing
Some pharmaceutical wholesalers are found to distribute a list to provide pharmacies with a higher rate of rebates from 10 to 35 percent to illegally promote sales of medicines produced by 84 drug makers, according to...
Drugmakers to be hit by whistleblower reward program
It has been a tough challenge for health authorities to break corrupt ties between drug makers, doctors and pharmacists. There are still many medical professionals who do not feel compunction about taking rebates from...
Boryung wins patent dispute against Sanofi Aventis
Boryung Pharm has been making strides in expanding its marketing scope in promising medications by successfully winning six patent disputes.
Boryung has won a patent infringement lawsuit of Taxotere (docetaxel) it ...
Chong Kun Dang gets GMP certification
Chong Kun Dang Pharmaceutical Co. has received the GMP (good manufacturing practice) certification from the National Sanitary Surveillance Agency of Brazil.
Penicillin antibiotic Xmoxicillin (amoxicillin + potassi...
Multinational firms’ advanced marketing techniques draws attention
Influenced by the government’s anti-rebate measures, more and more local pharmaceutical firms are rushing to benchmark the multinational companies’ marketing techniques, with a hope to boost their sales.
Experts p...
Clinics prefer calcium channel blockers
Many clinics tend to prescribe calcium channel blocker (CCB) in newly diagnosed hypertensive patents, while general hospitals prefer angiotensin II receptor blockers (ARB) in the meta-analyses of 42,016 without cardio...
Government urged to promote new prescription plan
MBC TV’s News Desk, a prime time news program, has recently reported that Sweden’s new pricing and reimbursement scheme in 2002.
The program said its main features are the use of cost-effectiveness analysis for de...
